Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle

Nature Protocols

Volumn 8, Issue 3, 2013, Pages 602-626

  Rosner, Margit ^a   Schipany, Katharina ^a   Hengstschläger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CELL TYPE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL SEPARATION; CELL SIZE; CELLS, CULTURED; CHEMICAL FRACTIONATION; CYTOPLASM; FLOW CYTOMETRY; HUMANS; MICE; PROTEINS;

EID: 84875134766     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2013.011     Document Type: Article

References (102)

1. Scott, J.D. & Pawson, T. Cell signaling in space and time: where proteins come together and when they're apart. Science 326, 1220-1224 (2009).
2. Murphy, L.O. & Blenis, J. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31, 268-275 (2006).
3. Zaidi, S.K. et al. Nuclear microenvironments in biological control and cancer. Nat. Rev. Cancer 7, 454-463 (2007).
4. Rajendran, L., Knölker, H.J. & Simons, K. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29-42 (2010).
5. Rosner, M., Schipany, K. & Hengstschläger, M. Spatial consequences of blocking mTOR/S6K: relevance for therapy. Cell Cycle 11, 420-421 (2012).
6. Keyomarsi, K. & Pardee, A.B. Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents. Prog. Cell Cycle Res. 5, 527-532 (2003).
7. Laplante, M. & Sabatini, D.M. mTOR signaling in growth control and disease. Cell 149, 274-292 (2012).
8. Rosner, M. & Hengstschläger, M. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum. Mol. Genet. 17, 2934-2948 (2008).
9. Roblek, M. et al. Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W. PLoS ONE 5, e10604 (2010).
10. Rosner, M. & Hengstschläger, M. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR. Oncogene 30, 4509-4522 (2011).
11. Rosner, M. & Hengstschläger, M. mTOR protein localization is cell cycle-regulated. Cell Cycle 15, 3608-3610 (2011).
12. Roederer, M. Multiparameter FACS analysis. Curr. Protoc. Immunol. 49, 5.8.1-5.8.10 (2002).
13. Krutzik, P.O., Crane, J.M., Clutter, M.R. & Nolan, G.P. High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4, 132-142 (2007).
14. Krutzik, P.O., Trejo, A., Schulz, K.R. & Nolan, G.P. Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. Methods Mol. Biol. 699, 179-202 (2011).
15. Darzynkiewicz, Z., Juan, G. & Traganos, F. Cytometry of cell cycle regulatory proteins. Prog. Cell Cycle Res. 5, 533-542 (2003).
16. Rosner, M., Schipany, K. & Hengstschläger, M. Phosphorylation of nuclear and cytoplasmic pools of ribosomal protein S6 during cell cycle progression. Amino Acids doi:10.1007/s00726-012-1445-1 (20 December 2012).
17. Conlon, I.J., Dunn, G.A., Mudge, A.W. & Raff, M.C. Extracellular control of cell size. Nat. Cell Biol. 3, 918-921 (2003).
18. Mitchison, J.M. Growth during the cell cycle. Int. Rev. Cytol. 226, 165-258 (2003).
19. Huber, M.D. & Gerace, L. The size-wise nucleus: nuclear volume control in eukaryotes. J. Cell Biol. 179, 583-584 (2007).
20. Maeshima, K., Iino, H., Hihara, S. & Imamoto, N. Nuclear size, nuclear pore number and cell cycle. Nucleus 2, 113-118 (2011).
21. Pardee, A.B. & Keyomarsi, K. Modification of cell proliferation with inhibitors. Curr. Opin. Cell Biol. 4, 186-191 (1992).
22. Davis, P.K., Ho, A. & Dowdy, S.F. Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques 30, 1322-1326 (2001).
23. Jackmann, J. & O'Connor, P.M. Methods for synchronizing cells at specific stages of the cell cycle. Curr. Protoc. Cell Biol. 8.3, 8.3.1-8.3.20 (2001).
24. Harper, J.V. Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol. Biol. 296, 157-166 (2005).
25. Banfalvi, G. Overview of cell synchronization. Methods Mol. Biol. 761, 1-23 (2011).
26. Kung, A.L., Zetterberg, A., Sherwood, S.W. & Schimke, R.T. Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res. 50, 7307-7317 (1990).
27. Urbani, L., Sherwood, S.W. & Schimke, R.T. Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization. Exp. Cell Res. 219, 159-168 (1995).
28. Gong, J., Traganos, F. & Darzynkiewicz, Z. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ. 6, 1485-1493 (1995).
29. Darzynkiewicz, Z., Halicka, H.D., Zhao, H. & Podhorecka, M. Cell synchronization by inhibitors of DNA replication induces replication stress and DNA damage response: analysis by flow cytometry. Methods Mol. Biol. 761, 85-96 (2011).
30. Miloloza, A. et al. The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum. Mol. Genet. 9, 1721-1727 (2000).
31. Soucek, T., Pusch, O., Wienecke, R., DeClue, J.E. & Hengstschläger, M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem. 272, 29301-29308 (1997).
32. Astrinidis, A., Senapedis, W., Coleman, T.R. & Henske, E.P. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B. J. Biol. Chem. 278, 51372-51379 (2003).
33. De Coppi, P. et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 25, 100-106 (2007).
34. Rosner, M. et al. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat. Protoc. 5, 1081-1095 (2010).
35. Rosner, M. & Hengstschläger, M. Cytoplasmic/nuclear localization of tuberin in different cell lines. Amino Acids 33, 575-579 (2007).
36. Rosner, M., Freilinger, A. & Hengstschläger, M. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene 26, 521-531 (2007).
37. Shelby, R.D., Monier, K. & Sullivan, K.F. Chromatin assembly at kinetochores is uncoupled from DNA replication. J. Cell Biol. 151, 1113-1118 (2000).
38. Soucek, T., Yeung, R. & Hengstschläger, M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95, 15653-15658 (1998).
39. Rosner, M. & Hengstschläger, M. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J. Biol. Chem. 279, 48707-48715 (2004).
40. Zhu, W., Giangrande, P.H. & Nevins, J.R. E2Fs link the control of G1/S and G2/M transcription. EMBO J. 23, 4615-4626 (2004).
41. Keyomarsi, K., Sandoval, L., Band, V. & Pardee, A.B. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51, 3602-3609 (1991).
42. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. & Reed, S.I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91, 5291-5295 (1994).
43. Rao, S. et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc. Natl. Acad. Sci. USA 96, 7797-7802 (1999).
44. Javanmoghadam-Kamrani, S. & Keyomarsi, K. Synchronization of the cell cycle using lovastatin. Cell Cycle 7, 2434-2440 (2008).
45. Lalande, M. A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell Res. 186, 332-339 (1990).
46. Kalejta, R.F. & Hamlin, J.L. The dual effect of mimosine on DNA replication. Exp. Cell Res. 231, 173-183 (1997).
47. Marraccino, R.L., Firpo, E.J. & Roberts, J.M. Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol. Biol. Cell 3, 389-401 (1992).
48. Park, S.Y. et al. Mimosine arrests the cell cycle prior to the onset of DNA replication by preventing the binding of human Ctf4/And-1 to chromatin via Hif-1α activation in HeLa cells. Cell Cycle 11, 761-766 (2012).
49. Bootsma, D., Budke, L. & Vos, O. Studies on synchronous division of tissue culture cells initiated by excess thymidine. Exp. Cell Res. 33, 301-309 (1964).
50. Thomas, D.B. & Lingwood, C.A. A model of cell cycle control: effects of thymidine on synchronous cell cultures. Cell 5, 37-42 (1975).
51. Mittnacht, S. & Weinberg, R.A. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65, 381-393 (1991).
52. Whitfield, M.L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977-2000 (2002).
53. Ikegami, S. et al. Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α. Nature 275, 458-460 (1978).
54. Pedrali-Noy, G. et al. Synchronization of HeLa cell cultures by inhibition of DNA polymerase αwith aphidicolin. Nucleic Acids Res. 8, 377-387 (1980).
55. Dulić, V., Stein, G.H., Far, D.F. & Reed, S.I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell Biol. 18, 546-557 (1998).
56. Adams, R.L. & Lindsay, J.G. Hydroxyurea reversal of inhibition and use as a cell-synchronizing agent. J. Biol. Chem. 242, 1314-1317 (1967).
57. Maurer-Schultze, B., Siebert, M. & Bassukas, I.D. An in vivo study on the synchronizing effect of hydroxyurea. Exp. Cell Res. 174, 230-243 (1988).
58. Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell Biol. 21, 4684-4699 (2001).
59. Taylor, E.W. The mechanism of colchicine inhibition of mitosis. I. Kinetics of inhibition and the binding of h3-colchicine. J. Cell Biol. 25, 145-160 (1965).
60. Romsdahl, M.M. Synchronization of human cell lines with colcemid. Exp. Cell Res. 50, 463-467 (1968).
61. Sherwood, S.W., Rush, D.F., Kung, A.L. & Schimke, R.T. Cyclin B1 expression in HeLa S3 cells studied by flow cytometry. Exp. Cell Res. 211, 275-281 (1994).
62. Hayashi, M.T., Cesare, A.J., Fitzpatrick, J.A., Lazzerini-Denchi, E. & Karlseder, J. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat. Struct. Mol. Biol. 19, 387-394 (2012).
63. Deysson, G. Antimitotic substances. Int. Rev. Cytol. 24, 99-148 (1968).
64. Zieve, G.W., Turnbull, D., Mullins, J.M. & McIntosh, J.R. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp. Cell Res. 126, 397-405 (1980).
65. Jansen-Dürr, P. et al. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90, 3685-3689 (1993).
66. Matsui, Y., Nakayama, Y., Okamoto, M., Fukumoto, Y. & Yamaguchi, N. Enrichment of cell populations in metaphase, anaphase, and telophase by synchronization using nocodazole and blebbistatin: a novel method suitable for examining dynamic changes in proteins during mitotic progression. Eur. J. Cell Biol. 91, 413-419 (2012).
67. Griffin, M.J. Synchronization of some human cell strains by serum and calcium starvation. In Vitro 12, 393-398 (1976).
68. Campisi, J., Morreo, G. & Pardee, A.B. Kinetics of G1 transit following brief starvation for serum factors. Exp. Cell Res. 152, 459-466 (1984).
69. Pardee, A.B. G1 events and regulation of cell proliferation. Science 246, 603-608 (1989).
70. Pagano, M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685 (1995).
71. Langan, T.J. & Chou, R.C. Synchronization of mammalian cell cultures by serum deprivation. Methods Mol. Biol. 761, 75-83 (2011).
72. Tobey, R.A. & Crissman, H.A. Preparation of large quantities of synchronized mammalian cells in late G1 in the pre-DNA replicative phase of the cell cycle. Exp. Cell Res. 75, 460-464 (1972).
73. Ley, K.D. & Murphy, M.M. Synchronization of mitochondrial DNA synthesis in Chinese hamster cells (line CHO) deprived of isoleucine. J. Cell Biol. 58, 340-345 (1973).
74. Cifuentes, E., Croxen, R., Menon, M., Barrack, E.R. & Reddy, G.P. Synchronized prostate cancer cells for studying androgen-regulated events in cell cycle progression from G1 into S phase. J. Cell Physiol. 195, 337-345 (2003).
75. Holley, R.W. & Kiernan, J.A. 'Contact inhibition' of cell division in 3T3 cells. Proc. Natl. Acad. Sci. USA 60, 300-304 (1968).
76. Polyak, K. et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994).
77. Nelson, P.J. & Daniel, T.O. Emerging targets: molecular mechanisms of cell contact-mediated growth control. Kidney Int. 61, S99-S105 (2002).
78. Haberichter, T. et al. A systems biology dynamical model of mammalian G1 cell cycle progression. Mol. Syst. Biol. 3, 84 (2007).
79. Elvin, P. & Evans, C.W. Cell adhesiveness and the cell cycle: correlation in synchronized BALB/c 3T3 cells. Biol. Cell 48, 1-9 (1983).
80. Morla, A.O., Draetta, G., Beach, D. & Wang, J.Y. Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell 58, 193-203 (1989).
81. Schorl, C. & Sedivy, J.M. Analysis of cell cycle phases and progression in cultured mammalian cells. Methods 41, 143-150 (2007).
82. Beyrouthy, M.J. et al. Identification of G1-regulated genes in normally cycling human cells. PLoS ONE 3, e3943 (2008).
83. Lindahl, P.E. Principle of a counter-streaming centrifuge for the separation of particles of different sizes. Nature 161, 648 (1948).
84. Kauffman, M.G., Noga, S.J., Kelly, T.J. & Donnenberg, A.D. Isolation of cell cycle fractions by counterflow centrifugal elutriation. Anal. Biochem. 191, 41-46 (1990).
85. Dulić, V., Lees, E. & Reed, S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257, 1958-1961 (1992).
86. Zickert, P., Wejde, J., Skog, S., Zetterberg, A. & Larsson, O. Growth-regulatory properties of G1 cells synchronized by centrifugal elutriation. Exp. Cell Res. 207, 115-121 (1993).
87. Hengstschläger, M., Pusch, O., Soucek, T., Hengstschläger- Ottnad, E. & Bernaschek, G. Quality control of centrifugal elutriation for studies of cell cycle regulations. Biotechniques 23, 232-234, 236-237 (1997).
88. Banfalvi, G. Cell cycle synchronization of animal cells and nuclei by centrifugal elutriation. Nat. Protoc. 3, 663-673 (2008).
89. Arndt-Jovin, D.J. & Jovin, T.M. Analysis and sorting of living cells according to deoxyribonucleic acid content. J. Histochem. Cytochem. 25, 585-589 (1977).
90. Widrow, R.J. & Laird, C.D. Enrichment for submitotic cell populations using flow cytometry. Cytometry 39, 126-130 (2000).
91. Juan, G., Hernando, E. & Cordon-Cardo, C. Separation of live cells in different phases of the cell cycle for gene expression analysis. Cytometry 49, 170-175 (2002).
92. Coquelle, A. et al. Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis. Biochem. Pharmacol. 72, 1396-1404 (2006).
93. Shapiro, H.M. Practical Flow Cytometry. John Wiley & Sons, 2003.
94. Darzynkiewicz, Z. et al. Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808 (1992).
95. Freilinger, A. et al. Tuberin activates the proapoptotic molecule BAD. Oncogene 25, 6467-6479 (2006).
96. Zhang, H., Stallock, J.P., Ng, J.C., Reinhard, C. & Neufeld, T.P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712-2724 (2000).
97. Fingar, D.C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16, 1472-1487 (2002).
98. Rosner, M., Hofer, K., Kubista, M. & Hengstschläger, M. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 22, 4786-4798 (2003).
99. Murakami, M. et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell Biol. 24, 6710-6718 (2004).
100. Ruvinsky, I. et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19, 2199-1211 (2005).
101. Rosner, M., Fuchs, C., Siegel, N., Valli, A. & Hengstchläger, M. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle. Hum. Mol. Genet. 18, 3298-3310 (2009).
102. Ekim, B. et al. mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Mol. Cell Biol. 31, 2787-2801 (2011).